# Mingxi Li

> Mingxi Li is a funding round investor at GT Healthcare Capital Partners backing Health Care. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [GT Healthcare Capital Partners](https://shizune.co/investors/profile/gt-healthcare-capital-partners)
- Location: Jingan, China
- Total investments: 1
- Last investment: Jun 2019
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/mingxi-li-86547937/

Mingxi Li is a funding round investor at GT Healthcare Capital Partners in Jingan focused on Health Care and Therapeutics. Dr. MingXi Li serves as Partner at GT Healthcare Capital Partners. Experienced with identifying innovative technologies and commercializing them, MingXi is a US trained professional focusing on life science sector with keen understanding of global and China healthcare market.He has established a track record of investing in China as well ascross-border transactions, and stayed well connected with industrial leaders, entrepreneurs, investors and academia in both China and US.MingXi serves on the board of a number of prominent pharmaceutical and diagnostic companies in China as well. He was Senior Director at Simcere Pharmaceutical Group from 2013 to 2017, and managed Simcere’s portfolio of investments (>150M USD) in various venture funds, including Cormorant Asset Management (MA, USA), Ally Bridge Group (HK), Partners Innovation Fund (MA, USA), PointGuard Ventures (CA, USA), Bohe Angels (Suzhou, China) and Tenyall Capital (Nanjing, China). He also served on the investment committee of Tenyall Capital.MingXi graduated with a B.S. in Biological Science and Biotechnology from Tsinghua University and has a Ph.D. in Biochemistry from University of Illinois at Urbana-Champaign.Earlier in his career, he worked in Jiuding Capital, covering Chinese pharma/IVD/hospital sectors, and later at Simcere Pharma/Bioscikin covering clinical and pre-clinical stage biopharma investments globally.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| GT Apeiron Therapeutics | GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology. The company develops breakthrough investigational medicines by harnessing the power of artificial intelligence, aiming to drastically increase efficiency throughout the drug discovery process. | $27M |  | Jun 11, 2019 |  |

1 of 1 investments shown.

## About GT Healthcare Capital Partners

VC Fund · Central, Hong Kong

GT Healthcare Capital Partners (“GT Healthcare”) is an Asia-based private investment partnership that specializes in healthcare investments around the globe that aim to change technology landscapes. GT Healthcare intends to provide capital and scale expertise to healthcare businesses in Asia / Greater China.

4 contacts available at GT Healthcare Capital Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Alan Au | Founder / Managing Partner | https://shizune.co/investors/profile/alan-au |
| Jai Hyun Kwon | Venture Partner | https://shizune.co/investors/profile/jai-hyun-kwon |
| Jason Yeung | Partner | https://shizune.co/investors/profile/jason-yeung |
| Mingxi Li | Partner | https://shizune.co/investors/profile/mingxi-li |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Mingxi Li invest in?

Mingxi Li invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Mingxi Li last invest?

The most recent investment recorded for Mingxi Li closed in Jun 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co